PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...
Begin your TipRanks Premium journey today. Amicus (FOLD) Company Description: Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for ...
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine brokerages that are covering the company, MarketBeat reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback